2007 Analytical Chemistry Clinical Development Trials 
Drug Discovery World
MARCH 7, 2023
Linda Powers, CEO, Northwest Biotherapeutics Powers has served as the Chairman of NW Bio since 2007, and as CEO since 2011. Powers taught for more than six years at the National Institutes of Health, on medical product development and commercialisation, and at Georgetown Law School as an adjunct professor.
The Pharma Data
NOVEMBER 5, 2020
Taveras will lead all research and non-clinical development functions supporting the company’s pipeline of investigational therapies. Prior to that, Taveras was vice president of Small Molecule Drug Discovery and CMC Development at Biogen Idec, and Alantos Pharmaceuticals, which was acquired by Amgen in 2007.
Expert insights. Personalized for you.
246 
Let's personalize your content